Full Text View
Tabular View
No Study Results Posted
Related Studies
Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
This study has been completed.
Study NCT00542165   Information provided by Sanofi-Aventis
First Received: October 9, 2007   Last Updated: October 10, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
BPH/LUTS/Sexual Functions
Additional conditions recognized in this trial
Hypertrophy
Prostatic Hyperplasia
More general conditions related to this trial
Genital Diseases, Male
Pathological Conditions, Anatomical
Prostatic Diseases
Interventions listed in this trial
Alfuzosin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services